Long‑Term Chlorpyrifos Exposure Linked to Over Two‑And‑Half Times Higher Parkinson’s Risk
UCLA researchers find that residential exposure to the pesticide chlorpyrifos may more than double the odds of developing Parkinson’s disease and reveal how the chemical harms brain cells.
Chlorpyrifos Exposure and Parkinson’s Risk
Researchers at UCLA Health examined data from participants in the university’s Parkinson’s Environment and Genes study. By linking California pesticide‑application records with participants’ residential and workplace histories, they estimated long‑term exposure to chlorpyrifos, a pesticide used for decades in agriculture.
The analysis revealed that individuals with prolonged residential exposure to chlorpyrifos had more than 2.5 times the risk of developing Parkinson’s disease compared with those who had no such exposure.
Understanding the Biological Mechanism
To explore how chlorpyrifos might contribute to the disease, the team exposed mice to the chemical in aerosol form for several weeks, mimicking a common environmental route of human exposure. The experiments demonstrated that chlorpyrifos disrupts the brain’s ability to clear damaged proteins, a process essential for neuronal health.
This disruption leads to the loss of dopamine‑producing neurons, the hallmark of Parkinson’s disease, which impairs the brain’s capacity to coordinate smooth, controlled movements.
Implications for Public Health
Parkinson’s disease affects nearly one million Americans, causing tremors, muscle stiffness, slowed movement, and coordination difficulties. While genetics play a role, environmental factors such as pesticide exposure are increasingly scrutinized.
Chlorpyrifos residential use was banned in the United States in 2001, and additional restrictions on agricultural applications were introduced in 2021, yet the chemical remains in use on many crops domestically and is widely applied abroad.
Because exposure can occur years before symptoms appear, identifying chlorpyrifos as a risk factor may help shape prevention strategies and inform neurological monitoring for previously exposed populations.
Future Directions
The study, published in Molecular Neurodegeneration, moves beyond establishing an association by pinpointing a cellular pathway that could become a target for protective interventions. Continued research may determine whether mitigating protein‑clearance dysfunction can reduce Parkinson’s risk among those exposed to chlorpyrifos.
Understanding how everyday chemicals affect brain health is essential for protecting vulnerable populations as we confront the growing burden of neurodegenerative disease.
